✓ AI summary
Summary of reporting by Axios • • 1 min read
4 Wire-neutral provisional

✓ No loaded language, vague sourcing, or framing detected.

White House withdraws Heidi Overton's nomination for FDA leadership

The White House has withdrawn Heidi Overton's nomination to lead the FDA due to a lack of congressional support. Overton faced opposition from both Democrats and some Republicans, particularly regarding her role in vaccine recommendations. The FDA has been led by acting Commissioner Kyle Diamantas since May.

People
Heidi Overton Robert F. Kennedy Jr. Bill Cassidy

The White House has withdrawn Heidi Overton's nomination to head the FDA, citing insufficient congressional support. Overton, nominated by Trump in August, faced opposition from Democrats and skepticism from some Republicans, particularly regarding her stance on childhood vaccine recommendations. The Senate Health Committee was set to vote on her nomination shortly. Since May, the FDA has been led by acting Commissioner Kyle Diamantas.

Key facts

  • Heidi Overton's FDA nomination was withdrawn due to lack of support.
  • Overton was nominated by Trump in August 2026.
  • Senator Bill Cassidy expressed concerns over Overton's vaccine recommendations.
  • The HELP committee was scheduled to vote on Overton's nomination.
  • Kyle Diamantas has been acting FDA Commissioner since May.
Read the full story at Axios

A short AI summary in our own words. The reporting belongs to Axios; we don't reproduce it.

Annotating as

Notes are private: only you can see them.

No note attached

of yours on this article.

Original vs. Neutral

Original Headline

Scoop: White House drops Heidi Overton's FDA nomination

Neutral Headline

White House withdraws Heidi Overton's nomination for FDA leadership